Keros Therapeutics had a revenue of 211.25M in the quarter ending Mar 31, 2025, with 6844.31%. This bring the company's revenue in the last twelve months to 214.71M, Decreased 5948.25%. In the fiscal year ending Dec 31, 2024, Keros Therapeutics had annual revenue of 3.55M with 2250.99% growth.